# TriplePoint Venture Growth BDC Corp.: overview TPVG · NYSE · CIK 1580345 · [Other](/sectors/other.md) · fiscal year ends Dec 31 Pages: [Overview](/companies/tpvg.md) · [Financials](/companies/tpvg/financials.md) · [Filings](/companies/tpvg/filings.md) · [Insiders](/companies/tpvg/insiders.md) Revenue is not reported in this company’s XBRL financial statements. ## Last eight quarters | Line item | Unit | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Revenue | $ | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Gross margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Operating margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Net margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Diluted EPS | $ per share | [0.35](/filings/0001580345-25-000032.md) | not reported | [0.27](/filings/0001580345-26-000021.md) | [0.28](/filings/0001580345-26-000025.md) | [0.26](/filings/0001580345-25-000032.md) | not reported | [0.23](/filings/0001580345-26-000021.md) | [0.21](/filings/0001580345-26-000025.md) | | Free cash flow | $ | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | - Revenue. XBRL not reported. - Gross margin (gross profit / revenue). XBRL not reported. - Operating margin (operating income / revenue). XBRL not reported. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss. Derived values: 12-month figure less the 9-month figure. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure. ## Last five fiscal years | Line item | Unit | FY (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) | | --- | --- | ---: | ---: | ---: | ---: | ---: | | Revenue | $ | not reported | not reported | not reported | not reported | not reported | | Gross margin | % | not reported | not reported | not reported | not reported | not reported | | Operating margin | % | not reported | not reported | not reported | not reported | not reported | | Net margin | % | not reported | not reported | not reported | not reported | not reported | | Diluted EPS | $ per share | [1.33](/filings/0001580345-24-000005.md) | [1.94](/filings/0001580345-25-000005.md) | [2.07](/filings/0001580345-26-000008.md) | [1.40](/filings/0001580345-26-000008.md) | [1.05](/filings/0001580345-26-000008.md) | | Free cash flow | $ | not reported | not reported | not reported | not reported | not reported | - Revenue. XBRL not reported. - Gross margin (gross profit / revenue). XBRL not reported. - Operating margin (operating income / revenue). XBRL not reported. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities. Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing. ## Insider purchases and sales The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/tpvg/insiders.md) None in coverage. ## Funds that report holding it From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md) | Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before | | --- | --- | ---: | ---: | --- | --- | | [TWO SIGMA INVESTMENTS, LP](/funds/1179392.md) | 2026-06-30 | $3.0m | 618,001 | | Reduced −232,938 | | [MARSHALL WACE, LLP](/funds/1318757.md) | 2026-06-30 | $1.7m | 337,655 | | Reduced −59,134 | | [Legal & General Group Plc](/funds/764068.md) | 2026-06-30 | $1.6m | 325,584 | | Added +14,054 | | [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $754.5k | 153,663 | | Reduced −2,883 | | [BANK OF AMERICA CORP /DE/](/funds/70858.md) | 2026-06-30 | $620.0k | 126,269 | | Added +58,083 | | [MORGAN STANLEY](/funds/895421.md) | 2026-06-30 | $601.5k | 122,506 | | Reduced −17,996 | | [WELLS FARGO & COMPANY/MN](/funds/72971.md) | 2026-06-30 | $569.5k | 115,985 | | Added +3,789 | | [UBS Group AG](/funds/1610520.md) | 2026-06-30 | $417.3k | 84,998 | | Reduced −122,619 | | [Kovack Advisors, Inc.](/funds/1728321.md) | 2026-06-30 | $401.6k | 79,219 | | Added +12,850 | | [LPL Financial LLC](/funds/1403438.md) | 2026-06-30 | $322.1k | 65,604 | | Reduced −1,775 | ## Recent filings [All 465 filings](/companies/tpvg/filings.md) | Filed | Accepted | Form | What it is | Accession | | --- | --- | --- | --- | --- | | 2026-10-15 | 21:32 ET | [8-K](/filings/0001580345-26-000032.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001580345-26-000032 | | 2026-09-22 | 20:50 ET | [SCHEDULE 13D](/filings/0001213900-26-102233.md) | Ownership report, active investor | 0001213900-26-102233 | | 2026-09-21 | 18:22 ET | [8-K](/filings/0001580345-26-000030.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001580345-26-000030 | | 2026-08-05 | 20:48 ET | [10-Q](/filings/0001580345-26-000025.md) | Quarterly report, period 2026-06-30 | 0001580345-26-000025 | | 2026-08-05 | 20:45 ET | [8-K](/filings/0001580345-26-000024.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001580345-26-000024 | | 2026-05-06 | 20:38 ET | [10-Q](/filings/0001580345-26-000021.md) | Quarterly report, period 2026-03-31 | 0001580345-26-000021 | | 2026-05-06 | 20:35 ET | [8-K](/filings/0001580345-26-000020.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001580345-26-000020 | | 2026-05-01 | 20:05 ET | [8-K](/filings/0001580345-26-000017.md) | 5.07 Shareholder vote results | 0001580345-26-000017 | | 2026-03-09 | 20:56 ET | [DEF 14A](/filings/0001580345-26-000011.md) | Proxy statement, period 2026-03-09 | 0001580345-26-000011 | | 2026-03-04 | 21:39 ET | [10-K](/filings/0001580345-26-000008.md) | Annual report, period 2025-12-31 | 0001580345-26-000008 | ## Latest annual report [Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001580345-26-000008.md), filed Mar 4, 2026. ## Forecast league Not in this season’s league. [This season’s league](/leagues.md) ## About the filer - CIK: 1580345 - Tickers: TPVG - Exchange: NYSE - SIC code: not reported - State of incorporation: MD - Filer category: Accelerated filer Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:43 ET. No prices; not investment advice.